X-49251441-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_014009.4(FOXP3):c.1189C>T(p.Arg397Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000178 in 112,222 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R397Q) has been classified as Pathogenic.
Frequency
Consequence
NM_014009.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXP3 | NM_014009.4 | c.1189C>T | p.Arg397Trp | missense_variant | 12/12 | ENST00000376207.10 | |
FOXP3 | NM_001114377.2 | c.1084C>T | p.Arg362Trp | missense_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXP3 | ENST00000376207.10 | c.1189C>T | p.Arg397Trp | missense_variant | 12/12 | 1 | NM_014009.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112222Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 34396
GnomAD3 exomes AF: 0.00000547 AC: 1AN: 182711Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67315
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1098073Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 363443
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112222Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 34396
ClinVar
Submissions by phenotype
Insulin-dependent diabetes mellitus secretory diarrhea syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2021 | This variant has been observed in individuals with clinical features of IPEX syndrome (PMID: 11137992, 11295725, 25546394, 30293990, 30443250, 31130284). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 11407). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with tryptophan at codon 397 of the FOXP3 protein (p.Arg397Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects FOXP3 protein function (PMID: 16920951, 22590469, 28778586, 28783662). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FOXP3 protein function. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2001 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 03, 2021 | Variant summary: FOXP3 c.1189C>T (p.Arg397Trp) results in a non-conservative amino acid change located in the Fork head domain (IPR001766) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 182711 control chromosomes (gnomAD). c.1189C>T has been reported in the literature in multiple individuals affected with Insulin-Dependent Diabetes Mellitus Secretory Diarrhea Syndrome (Wildin_2001, Xavier-DaSilva_2015, Gambineri_2018, Quinlan Jones_2019, Shangaris_2021). These data indicate that the variant is associated with disease. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Hydrops fetalis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetics - Synnovis, NHS South East Genomic Laboratory Hub | Mar 02, 2020 | This variant detected in two affected male fetuses and not detected in an unaffected male fetus (consecutive pregnancies). The same variant reported by Xavier-da-Silva (2015) in a fetus presenting with hydrops at 27 weeks' gestation and in a term newborn who developed diabetes mellitus during the first hours of life. Levy-Lahad & Wildin (2001) also reported this variant in three siblings presenting with IPEX manifestations at birth. In all previously reported cases, the pathological process began during intrauterine life; furthermore, there are no survivors described. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at